Found: 29
Select item for more details and to access through your institution.
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 350, doi. 10.1634/theoncologist.2014-0028
- By:
- Publication type:
- Article
A Case of Small Bowel Obstruction Due to Intraluminal Metastases from Metastatic Renal Cell Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 2, p. 95, doi. 10.1634/theoncologist.2006-0214
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors.
- Published in:
- Oncologist, 2007, v. 12, n. 4, p. 426, doi. 10.1634/theoncologist.12-4-426
- By:
- Publication type:
- Article
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.
- Published in:
- Canadian Urological Association Journal, 2014, v. 8, n. 11/12, p. 398, doi. 10.5489/cuaj.2426
- By:
- Publication type:
- Article
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Quality of life in patients with K- RAS wild-type colorectal cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 2, p. 181, doi. 10.1002/cncr.28410
- By:
- Publication type:
- Article
Quality of life in patients with K-RAS wild-type colorectal cancer: The CO.20 Phase 3 Randomized Trial.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2692, doi. 10.1002/cncr.28117
- By:
- Publication type:
- Article
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Molecular Predictors of Outcome in a Phase 3 Study of Gemcitabine and Erlotinib Therapy in Patients With Advanced Pancreatic Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 24, p. 5599, doi. 10.1002/cncr.25393
- By:
- Publication type:
- Article
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prostate cancer: 9. Treatment of advanced disease.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1999, v. 160, n. 2, p. 225
- By:
- Publication type:
- Article
Targeting Metastatic Prostate Cancer: The Search for Innovative Systemic Therapies.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1787
- By:
- Publication type:
- Article
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt347
- By:
- Publication type:
- Article
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 11, p. 863, doi. 10.1093/jnci/djr153
- By:
- Publication type:
- Article
Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 17, p. 1182, doi. 10.1093/jnci/djp232
- By:
- Publication type:
- Article
Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 676, doi. 10.1002/cncr.22036
- By:
- Publication type:
- Article
Depression and use of health care services in patients with advanced cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 779, doi. 10.1007/s10637-010-9611-3
- By:
- Publication type:
- Article
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 8, p. 1313, doi. 10.1093/jnci/djae077
- By:
- Publication type:
- Article
Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 3, p. 475, doi. 10.1080/02841860802446779
- By:
- Publication type:
- Article
Eyelid metastasis from mediastinal teratoma with malignant transformation.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 8, p. 1200, doi. 10.1080/02841860701316073
- By:
- Publication type:
- Article
Outcome and Toxicity of Postoperative Short Course Adjuvant Radiation and Chemotherapy following Resection of Adenocarcinoma of the Rectum.
- Published in:
- Acta Oncologica, 2004, v. 43, n. 6, p. 567, doi. 10.1080/02841860410014939
- By:
- Publication type:
- Article
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 2, p. 147, doi. 10.1001/jama.2012.7352
- By:
- Publication type:
- Article
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 2, p. 154, doi. 10.1007/s00280-004-0942-7
- By:
- Publication type:
- Article
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147995
- By:
- Publication type:
- Article
Technetium-99m-Furifosmin as an Agent for Functional Imaging of Multidrug Resistance in Tumors.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 12, p. 1915
- By:
- Publication type:
- Article
Technetium-99m-Tetrofosmin as a Substrate for P-Glycoprotein: In Vitro Studies in Multidrug-Resistant Breast Tumor Cells.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 9, p. 1578
- By:
- Publication type:
- Article